Family offices increase April direct investments, with healthcare taking nearly a third
Updated
Updated · CNBC · May 7
Family offices increase April direct investments, with healthcare taking nearly a third
7 articles · Updated · CNBC · May 7
Fintrx data showed 55 deals in April, up from 39 in March, as activity rebounded after the Iran war slowdown.
Healthcare and life sciences drew strong backing, including Emerson Collective investments in Ultralight and Stipple Bio, while Dolby Family Ventures joined Exciva's 53 million euro Series B.
J.P. Morgan's February survey ranked healthcare innovation behind only AI among family-office themes, as private capital rises amid Trump administration proposals to cut another $5 billion from NIH.
As billionaires fund biotech amid government cuts, will life-saving innovations become a luxury good?
Can the patient capital of the ultra-rich truly secure the future of medicine for everyone?